Keely leverages HCP, patient and payer insights to inform market access, launch and commercial decisions.

Keely has worked in consulting since 2014 and is focused on strategy, insights and planning, and has spent time in ZS’s Philadelphia and London offices.

Keely works across therapeutic areas, recently focused on vaccines, HIV and rare diseases within the U.S. and EU markets. She leads projects that develop insights for launch strategy and marketing decisions, including early pipeline asset evaluations, go-to-market strategy projects, and pricing and access strategy. 

Prior to joining ZS, Keely completed a master’s of science in public health, where she worked on a research project for the Commonwealth Fund that sought to identify coordinated care models in the U.S. that successfully treated high-cost/high-needs patients with multiple chronic conditions. She also implemented a tool for the Maryland Department of Health to assess the capacity for health data collection within school health programs.

Keely holds a master’s of science in public health and health policy from Johns Hopkins Bloomberg School of Public Health, and a bachelor’s of science in biology from the University of California, San Diego.